AGL 38.20 Increased By ▲ 0.21 (0.55%)
AIRLINK 211.50 Decreased By ▼ -4.03 (-1.87%)
BOP 9.48 Decreased By ▼ -0.32 (-3.27%)
CNERGY 6.52 Decreased By ▼ -0.27 (-3.98%)
DCL 9.00 Decreased By ▼ -0.17 (-1.85%)
DFML 38.23 Decreased By ▼ -0.73 (-1.87%)
DGKC 96.86 Decreased By ▼ -3.39 (-3.38%)
FCCL 36.55 Decreased By ▼ -0.15 (-0.41%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 14.98 Increased By ▲ 0.49 (3.38%)
HUBC 131.00 Decreased By ▼ -3.13 (-2.33%)
HUMNL 13.44 Decreased By ▼ -0.19 (-1.39%)
KEL 5.51 Decreased By ▼ -0.18 (-3.16%)
KOSM 6.87 Decreased By ▼ -0.45 (-6.15%)
MLCF 44.90 Decreased By ▼ -0.97 (-2.11%)
NBP 59.34 Decreased By ▼ -1.94 (-3.17%)
OGDC 230.00 Decreased By ▼ -2.59 (-1.11%)
PAEL 39.20 Decreased By ▼ -1.53 (-3.76%)
PIBTL 8.38 Decreased By ▼ -0.20 (-2.33%)
PPL 200.00 Decreased By ▼ -3.34 (-1.64%)
PRL 39.10 Decreased By ▼ -1.71 (-4.19%)
PTC 27.00 Decreased By ▼ -1.31 (-4.63%)
SEARL 103.32 Decreased By ▼ -5.19 (-4.78%)
TELE 8.40 Decreased By ▼ -0.34 (-3.89%)
TOMCL 35.35 Decreased By ▼ -0.48 (-1.34%)
TPLP 13.46 Decreased By ▼ -0.38 (-2.75%)
TREET 25.30 Increased By ▲ 0.92 (3.77%)
TRG 64.50 Increased By ▲ 3.35 (5.48%)
UNITY 34.90 Increased By ▲ 0.06 (0.17%)
WTL 1.77 Increased By ▲ 0.05 (2.91%)
BR100 12,110 Decreased By -137 (-1.12%)
BR30 37,723 Decreased By -662.1 (-1.72%)
KSE100 112,415 Decreased By -1509.6 (-1.33%)
KSE30 35,508 Decreased By -535.7 (-1.49%)
Markets

European shares extend gains after German PMI relief

The pan-European STOXX 600 climbed 1.2pc following four consecutive sessions of declines. The report added to
Published January 24, 2020
  • The pan-European STOXX 600 climbed 1.2pc following four consecutive sessions of declines.
  • The report added to investor relief after the World Health Organization stopped short of calling a virus outbreak in China a global emergency.
  • Investors are now waiting for UK PMI readings, due at 0930 GMT.

European shares extended gains on Friday after a key monthly business activity report from Germany suggested the euro zone's largest economy may be picking up some steam at the start of 2020.

The report added to investor relief after the World Health Organization stopped short of calling a virus outbreak in China a global emergency.

The pan-European STOXX 600 climbed 1.2pc following four consecutive sessions of declines.

Germany's DAX was on course for its best day in about two weeks after IHS Markit's Purchasing Managers' Index (PMI) showed the country's private sector gained momentum in January and a pullback in manufacturing had eased.

The report comes on the heels of a ZEW survey, which showed the recent truce in the U.S.-China trade dispute left German investors at their most optimistic since mid-2015.

The PMI data "seems to confirm (European Central Bank President) Lagarde's remarks that the economic risks have become less pronounced so that's a positive," said Teeuwe Mevissen, senior eurozone market economist at Rabobank.

"At the same time she said interest rates will remain low for the foreseeable future so even as the risks have become less pronounced, markets can still count on the ECB to maintain interest rates at very low levels."

Lagarde struck a slightly more dovish tone than some had expected following the central bank's first policy meeting of he year on Thursday.

Gains in bank stocks provided the biggest support to the benchmark index. All major European subsectors were trading higher.

Investors are now waiting for UK PMI readings, due at 0930 GMT, which will be crucial ahead of the Bank of England's interest rate decision next week.

Among stocks, Bayer provided the biggest boost to DAX after a report on a possible out-of-court settlement of a U.S. jury trial over allegations that its weed killer Roundup causes cancer.

Swedish telecoms equipment group Ericsson was on track for its worst day in about six months after it reported a smaller-than-expected rise in fourth-quarter core earnings. Shares of its rival Nokia slipped 0.8pc.

Nokian Tyres hit a more than three month low as the Finnish tyre maker forecast its 2020, sales and operating result to significantly decline from a year earlier due to weak performance in its Russia operations.

Shares of French pharma company Ipsen tumbled 22pc to the bottom of STOXX 600 after it paused dosing in rare bone diseases drug, palovarotene.

Comments

Comments are closed.